Medline Industries, a medical supplies giant backed by PE firms Blackstone, Carlyle, and Hellman & Friedman, has confidentially filed for a US IPO, setting the stage for a 2025 listing that could value the company as high as $50bn, according to report by Reuters.
If successful, the IPO would be one of the most significant private equity-backed listings of the decade.
While the size of the offering has not been finalised, sources suggest the IPO could raise up to $5bn, presenting a lucrative exit opportunity for its private equity owners who acquired Medline in a $34bn deal in 2021, one of the largest leveraged buyouts of the past decade.
Since the 2021 acquisition, Blackstone, Carlyle, and Hellman & Friedman have focused on operational efficiencies and growth opportunities, preparing the company to go public.
Founded in 1966 and headquartered in Northfield, Illinois, Medline is one of the largest global manufacturers and distributors of medical supplies. Its product portfolio includes surgical equipment, gloves, and laboratory devices essential to hospitals and healthcare providers worldwide.
